Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-09-15
2000-12-12
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514252, 514253, 514241, 514245, 514242, 5142358, 5142322, 5142278, 544408, 544180, 544182, 544295, 544212, 544219, 544 82, 544120, 544 586, C07D24118, A61K 31495
Patent
active
061599808
ABSTRACT:
Corticotropin releasing factor (CRF) antagonists of Formula (I) ##STR1## and their use in treating psychiatric disorders and neurological diseases including major depression, anxiety-related disorders, post-traumatic stress disorders, supranuclear palsy and eating disorders.
REFERENCES:
patent: 5418233 (1995-05-01), Linz et al.
patent: 5518994 (1996-05-01), Kawamura et al.
Appleton et al, Chemical Abstracts, vol. 93 entry 114569 (1980).
H. Neunhoeffer, 1,2,4-Triazines and the Benzo Derivatives, Comprehensive Heterocyclic Chemistry, Katritsky & Rees, ed, vol. 3, pp. 385-456, 1984.
Nakamura et al., Agric. Biol. Chem., 47 (7), 1561-1567, 1983.
Arnold, III Charles R.
Arvanitis Argyrios Georgios
Frietze William E.
Olson Richard E.
DuPont Pharmaceuticals Company
Ford John M.
Larsen Scott K.
LandOfFree
Pyrazinones and triazinones and their derivatives thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazinones and triazinones and their derivatives thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazinones and triazinones and their derivatives thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-217943